Cargando…
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults
BACKGROUND: This first in human study was designed as an open label clinical trial to assess safety and tolerability of Serum Institute of India Pvt. Ltd. (SIIPL) quadrivalent HPV (qHPV) vaccine. METHODS: A total of 48 healthy male and female (24 each) adult volunteers were administered a 0.5 ml sin...
Autores principales: | Sharma, Hitt, Anil, K., Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Madhusudhan, R.L., Patel, Jaya, Eswaraiah, Anand, Rao, Harish, Gairola, Sunil, Shaligram, Umesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205786/ https://www.ncbi.nlm.nih.gov/pubmed/37234594 http://dx.doi.org/10.1016/j.jvacx.2023.100313 |
Ejemplares similares
-
A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
por: Sharma, Hitt, et al.
Publicado: (2023) -
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months
por: Sharma, Hitt, et al.
Publicado: (2022) -
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin
por: Rathod, Vishal, et al.
Publicado: (2023) -
Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2017) -
The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus
por: Dhar, J. Patricia, et al.
Publicado: (2018)